June 5, 2012
Malignant hyperthermia: A crisis response plan
Malignant hyperthermia (MH) is a genetic skeletal muscle disorder that is incited by anesthesia drugs including succinlycholine and inhaled anesthetic agents (Gurunluoglu et al, 2009; Hopkins, 2011; Kim et al, 2011). The disorder is particularly dangerous because it rapidly develops into a hypermetabolic state resulting in hyperpyrexia, tachycardia, and intense and unrelenting muscle contraction as well as alterations in electrolyte and acid-base balance (Kim et al, 2011).
Free Daily News
- Mentorship, peer support earn 9 nurses promotions at Madigan AMC
- Study: Weight-loss surgical procedures among teens on the rise
- Use of AI to predict risk of HAIs
- The Joint Commission: Deadline for CY 2022 ORYX performance measurement data submission is June 14
- Study: Post COVID-19 neuroinflammation with persistent depressive, cognitive symptoms
- The Joint Commission: Updates added to Health Care Equity Certification Resource Center
- Automatic surgical skill assessment using AI
- Nursing students learn to deal with patient deaths through simulations
- Increases, decreases to periop travel nurse pay
- Does golf swing contribute excessive force to hip implant after THA?
- Cardiothoracic Surgery APP - Atrium Health Wake Forest Baptist - Winston-Salem, NC
- Spine Surgery Opportunity in Greenville, NC - ECU Health - Greenville, NC
- Plastic Surgery Opportunities in Greenville, NC - ECU Health - Greenville, NC
- Thoracic Surgeon/WVU Heart & Vascular Institute - WVU Medicine - , WV
© Access Intelligence, LLC. All rights reserved. | Privacy Policy | Diversity Inclusion & Equity